Specialty doctors like rheumatologists, dermatologists, gastroenterologists, neurologists, and ophthalmologists have seen a big rise in the costs to run their offices. A study by Spherix Global Insights talked to over 300 specialists and found that more than half had expenses go up by over 20% last year. Several reasons explain this increase:
These problems together put the future of specialty practices at risk. Many wonder if they can keep working profitably given these challenges.
Rising medicine prices affect how doctors treat patients. More patients ask for cheaper generic drugs to avoid spending too much on branded medicines. This was reported by many doctors in the Spherix study.
Biologics are important drugs for illnesses like rheumatoid arthritis and inflammatory bowel disease but are very costly. Specialists say these are harder to prescribe because of their price and insurance hurdles.
Insurance companies have made it tougher to get approval and payment for expensive drugs. This creates extra work and financial strain on practices. It can also delay or stop patients from getting their needed treatments.
Because of the cost pressures, specialty practices are changing how they run daily tasks. Some are rethinking staff setups, how they buy supplies, and how they talk to patients to save money but still offer good care. Not all practices can adjust easily, and some question their future.
The COVID-19 pandemic sped up using telemedicine. This helped some practices by allowing remote visits and lowering office costs. But telemedicine does not work well for every specialty or patient. Some health issues need physical exams or special treatments done in the office.
Practices also try new ways to work with drug companies or buy medicines in groups to pay less. Still, rising costs for supplies, staff, medicines, and fewer patient visits keep making it hard to keep a steady business.
Retail health providers like Walgreens, CVS, and Walmart face similar cost and payment challenges as specialty practices. In 2024, Walgreens closed about half of its VillageMD clinics and plans to shut 1,200 stores because of financial problems. CVS Health has cut jobs and closed some pharmacies but is growing primary care through Oak Street Health. Walmart closed 51 clinics and stopped virtual care services.
These changes show how hard it is to keep running specialty and integrated care in today’s financial climate. Walgreens is trying a mixed approach with more virtual care in 30 states. Amazon is investing in technology and working with health systems like Cleveland Clinic. These efforts show different ways companies try to manage health services with rising costs.
One area that may help reduce costs is using artificial intelligence (AI) and workflow automation. These tools help with front-office tasks such as answering phones, scheduling appointments, and sorting patient needs.
Specialty offices get many calls every day about appointments and prescription refills. AI phone systems can handle these calls so staff can focus on harder tasks. Companies like Simbo AI make phone solutions that reduce work for receptionists and call centers.
By automating calls, confirming appointments, and reminding patients, AI helps reduce missed calls and improves how fast patients get answers. This leads to happier patients and more visits, which helps practices keep their income despite fewer office visits overall.
Automation also helps manage billing and insurance claims. It reduces mistakes and speeds up tasks like insurance checks, prior authorizations, and follow-ups on payments.
This makes revenue flow faster and avoids delays or denied payments. For specialty practices, this is important because of complex rules for expensive medicines and treatments.
AI can study big sets of data about patients, appointments, and treatments to find ways to improve practice efficiency. AI tools can help leaders decide which patients can use telehealth, which medicines fit budgets, or how to plan staff schedules better.
These tools help practice leaders adjust in time to cut costs and keep the practice running well.
Practice administrators and IT managers must understand how rising costs and patient habits affect specialty care. They need to find smart ways to hire and keep employees and make deals with suppliers. Investments in technology should focus on automating patient communication and office tasks.
Using AI phone systems and workflow tools lowers costs and improves how patients are served. This can help keep revenue steady when fewer patients visit but access to care stays important.
It is also important to use technology that fits with insurance and billing rules. The systems should change easily with new rules and also support telemedicine and other care models.
Specialty practice managers and owners must carefully plan how to control costs. They should also make use of new tools like AI to keep things running smoothly. Rising prices and insurance changes mean they need flexible operations and good tech choices to keep specialty care going in the United States.
The economic challenges include increased labor costs, difficulty in hiring and retaining staff, higher office and medical supply costs, and decreased patient visits, largely due to the inflationary economy and the lingering effects of COVID-19.
Inflation has led patients to make financially-driven decisions, such as skipping office visits and deferring specialist consultations, which could have long-term health implications.
Patients are increasingly opting for generics over expensive branded medications, often asking for samples or cheaper alternatives due to their financial constraints.
Specialties like rheumatology, dermatology, and gastroenterology report significant burdens due to the costs associated with prescribing biologics and other expensive treatments.
Reimbursement challenges from insurance companies, especially for branded products, create additional complications in getting necessary medications to patients.
Telemedicine has become pervasive; however, acceptance and comfort levels for starting and switching therapies vary by specialty, affecting patient interaction.
The financial strain is causing many practices to reassess operational strategies, with some finding it financially unfeasible to continue under current economic conditions.
Practices are continuously adapting by modifying interactions with patients and industry to manage the economic impact more effectively.
Prescribing biologics, particularly JAK inhibitors, IL-6 inhibitors, and anti-CGRP products, has become increasingly challenging due to their costs and reimbursement issues.
Many physicians express doubts about the financial viability of their practices in the face of ongoing economic pressures and operational hardships.